Excelsior Biopharma (6496.TWO) Stock Price
Excelsior Biopharma Price
Over the last 14 years Excelsior Biopharma grew revenue by 0.7% annually, reaching 898.26 M TWD. Earnings per share have declined at 29.5% per year over the last 9 years. For Excelsior Biopharma, the net margin of -20.4% is down versus -1.2% a few years ago.
Excelsior Biopharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Excelsior Biopharma business model & stock analysis
Frequently asked questions about Excelsior Biopharma
Converted at the current exchange rate, the Excelsior Biopharma share trades at 0.62 EUR (22.85 TWD).
The revenue cannot currently be calculated for Excelsior Biopharma.
The profit cannot currently be calculated for Excelsior Biopharma.
The P/E ratio cannot be calculated for Excelsior Biopharma at the moment.
The P/S cannot be calculated for Excelsior Biopharma currently.
The Eulerpool Quality Score for Excelsior Biopharma is 4/10.
The ISIN of Excelsior Biopharma is TW0006496003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Excelsior Biopharma is 6496.TWO. The ticker symbol is used to trade Excelsior Biopharma shares on the stock exchange.
Excelsior Biopharma stock
Excelsior Biopharma Peer Group
Excelsior Biopharma FIGI
All fundamentals and in-depth analysis of Excelsior Biopharma
Our stock analysis for Excelsior Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Excelsior Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.